Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.

With new research showing current cardiovascular disease screening guidelines are missing younger at-risk Aboriginal people, a leading Aboriginal health specialist has highlighted the role...

Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.

Delegates from the 43rd annual PSA Offshore Refresher conference have recently returned from host city San Francisco, where they networked while learning about the...

In 2023 pharmacists will be the custodians of medicine safety, embedded wherever medicines are used, and more responsible and accountable for the safe and...